Tamari M - Search Results

1

Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex.

Hatano T, Endo K, Tamari M. Hatano T, et al. Among authors: tamari m. Int J Clin Oncol. 2021 Jan;26(1):163-168. doi: 10.1007/s10147-020-01792-w. Epub 2020 Sep 29. Int J Clin Oncol. 2021. PMID: 32990779

2

Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization.

Hatano T, Matsu-Ura T, Mori KI, Inaba H, Endo K, Tamari M, Egawa S. Hatano T, et al. Among authors: tamari m. Int J Clin Oncol. 2018 Dec;23(6):1134-1139. doi: 10.1007/s10147-018-1325-0. Epub 2018 Aug 1. Int J Clin Oncol. 2018. PMID: 30069798

3

Hyperprogression after pembrolizumab treatment in two patients with metastatic urothelial carcinoma.

Hatano T, Matsu-Ura T, Mori KI, Inaba H, Endo K, Tamari M, Egawa S. Hatano T, et al. Among authors: tamari m. Jpn J Clin Oncol. 2019 May 1;49(5):473-476. doi: 10.1093/jjco/hyz038. Jpn J Clin Oncol. 2019. PMID: 30920617

4

Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex.

Hatano T, Ohno Y, Imai Y, Moritake J, Endo K, Tamari M, Egawa S. Hatano T, et al. Among authors: tamari m. Orphanet J Rare Dis. 2020 Jun 1;15(1):133. doi: 10.1186/s13023-020-01417-5. Orphanet J Rare Dis. 2020. PMID: 32487130 Free PMC article.

5

[OVERVIEW OF GENETICS ANALYSIS FOR ALLERGIC DISEASES].

Hirota T, Inoue N, Tamari M. Hirota T, et al. Among authors: tamari m. Arerugi. 2020;69(9):869-875. doi: 10.15036/arerugi.69.869. Arerugi. 2020. PMID: 33191373 Review. Japanese. No abstract available.

6

[GENETIC FACTORS FOR THE DEVELOPMENT OF ALLERGIC DISORDERS].

Tamari M, Hirota T. Tamari M, et al. Arerugi. 2018;67(8):1006-1010. doi: 10.15036/arerugi.67.1006. Arerugi. 2018. PMID: 30249949 Japanese. No abstract available.

7

Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti-tumor necrosis factor therapy in Japanese patients with psoriasis.

Ito M, Hirota T, Momose M, Ito T, Umezawa Y, Fukuchi O, Asahina A, Nakagawa H, Tamari M, Saeki H. Ito M, et al. Among authors: tamari m. J Dermatol. 2020 Apr;47(4):e110-e111. doi: 10.1111/1346-8138.15200. Epub 2019 Dec 23. J Dermatol. 2020. PMID: 31872456 No abstract available.

8

Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting.

Asano K, Tamari M, Zuberbier T, Yasudo H, Morita H, Fujieda S, Nakamura Y, Traidl S, Hamelmann E, Raap U, Babina M, Nagase H, Okano M, Katoh N, Ebisawa M, Renz H, Izuhara K, Worm M. Asano K, et al. Among authors: tamari m. Allergol Int. 2022 Jul;71(3):310-317. doi: 10.1016/j.alit.2022.05.003. Epub 2022 Jun 2. Allergol Int. 2022. PMID: 35662539 Free article.

9

Genetic impact of CDHR3 on the adult onset of asthma and COPD.

Shigemasa R, Masuko H, Hyodo K, Kitazawa H, Kanazawa J, Yatagai Y, Iijima H, Naito T, Saito T, Hirota T, Tamari M, Sakamoto T, Hizawa N. Shigemasa R, et al. Among authors: tamari m. Clin Exp Allergy. 2020 Nov;50(11):1223-1229. doi: 10.1111/cea.13699. Epub 2020 Jul 23. Clin Exp Allergy. 2020. PMID: 32615023

10

Associations of TNFAIP3 variants with susceptibility to psoriasis vulgaris and psoriasis arthritis in a Japanese population.

Momose M, Hirota T, Kikuchi S, Inoue N, Umezawa Y, Nakagawa H, Saeki H, Tamari M, Asahina A. Momose M, et al. Among authors: tamari m. J Dermatol Sci. 2020 Dec;100(3):220-222. doi: 10.1016/j.jdermsci.2020.09.005. Epub 2020 Sep 19. J Dermatol Sci. 2020. PMID: 32998836 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters